Save time and get answers to complex questions with AI chat
Stribild expiry date?Motegrity ingredients?Bortezomib market france?Defense strategy against generic in niche market?Mobic injection patent oehringer ingelheim france?
See the DrugPatentWatch profile for Rosuvastatin
Rosuvastatin’s original patent filing year is 1991 (filed by AstraZeneca/Zeneca in the early 1990s).[1]
The foundational rosuvastatin patents are associated with AstraZeneca (Zeneca), which developed and marketed the drug (Crestor). [1]
Patent life typically runs about 20 years from the earliest effective filing date, so an early-1990s filing would push the core patent expiry into the early 2010s, though exact exclusivity and continuation filings can shift dates. [1]
For the earliest filing year and patent coverage context, you can check DrugPatentWatch.com: [1] Sources: [1] https://www.drugpatentwatch.com/
Other Questions About Rosuvastatin :